The Emirates Dermatology Society (EDS) and LEO Pharma have signed a Memorandum of Understanding (MoU) to strengthen awareness, support earlier diagnosis, and improve the management of Chronic Hand Eczema (CHE) across the UAE.
The agreement was signed during the opening of LEO Pharma’s new regional office at Expo City Dubai, marking a key milestone in the company’s regional growth strategy and expanding its presence in the Gulf.
Under the partnership, EDS and LEO Pharma will collaborate to promote earlier recognition of Chronic Hand Eczema symptoms, enhance patient education, engage healthcare professionals, and improve access to timely diagnosis and disease management.
Also read: First Robotic Mitral Valve Repair Successfully Performed in Dubai
Frederik Kier, Executive Vice President, International Operations, LEO Pharma, stated: “Chronic Hand Eczema places a considerable burden on patients, affecting not only their physical health but also their emotional well-being, social participation and professional lives. By bringing together the expertise of the Emirates Dermatology Society and LEO Pharma’s global medical dermatology leadership, we can improve education and support earlier diagnosis and management of the disease. This partnership, together with our expanded presence in Dubai, demonstrates our long-term commitment to supporting patients, healthcare professionals, and the future of dermatology care across the UAE and the wider region.”
The new Dubai office will serve as the headquarters for LEO Pharma’s Emerging Markets leadership team, strengthening collaboration with dermatologists, healthcare providers, government entities, and industry partners. The company said the expansion will help accelerate access to innovative dermatology solutions across the Gulf Cooperation Council (GCC) and other emerging markets.
The partnership reflects the shared commitment of both organizations to advancing dermatology care and improving outcomes for people living with chronic skin conditions in the region.
